If you’ve found yourself unexpectedly humming the tune “Magic” lately, you’re not alone. Thanks to the catchy commercial for ...

Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

GlobalData’s report assesses the drugs in the Glucagon Like Peptide 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

If you were prescribed a GLP-1, it's important that you understand how your insurance coverage works in order to stay on top ...

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

French researchers have developed a new drug delivery system that could cut the dosing schedule for the type 2 diabetes and ...

Offering comprehensive, seamless obesity and digestive health support is the best way for employers to address rising costs ...

The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current ...

Ken Cohen, MD, of Optum Care, advocates for glucagon-like peptide 1 (GLP-1) tiering for patients with diabetes based on comorbidities, like body mass index (BMI) and cardiovascular disease (CVD).

Ingredient supplier IFF’s portfolio reflects evolving consumer demands and emerging trends in weight management , including ...

An injectable hydrogel provided a sustained release of semaglutide for 1 month in rats, according to preclinical testing of ...